Latest immune responses News

Risk of long COVID builds each time you get infected
Victoria’s first mRNA innovation hub backed by state government
Kids’ noses can better fight Covid
COVID vaccine patch fights variants better than needles
Maternal antibodies may protect babies from cytomegalovirus
Study reveals new mode of triggering immune responses
Anti-rejection medication and immunotherapy kicks cancer and protects kidney transplants
Elucidation of antiviral/innate immune response activation mechanism of hepatokine LECT2
Ludwig Oxford Member Yang Shi elected Member of European Molecular Biology Organization
Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN Phase III trial
COPD patients respond equally well to Covid vaccine
Attention Queenslanders – Your help needed for landmark Covid study
Interim statement on composition of current Covid vaccines
Interim statement on decision-making considerations for use of variant updated Covid vaccines
Australian drug trial aims to reduce hospital visits for kids with asthma
T cell behavior determines immunotherapy success
CSIRO’s future science to tackle energy storage, carbon locking, immune resilience and bioeconomy
Key protein facilitates regeneration of liver blood vessels
Participants sought for state-wide Covid vaccine study
Two distinct tuberculosis subtypes IDed – implications for personalized therapy
Expert commentary: fourth Covid vaccine dose for at-risk Australians
Study reveals structure of anti-tumor therapy’s target
Four Ludwig Cancer Research scientists named Fellows of American Association for Cancer Research
Potential new Covid immunotherapy could protect vulnerable
Why does COVID mutate and will we see more variants?
Inhalable aerogel triggers immunity to Covid in mice, may block transmission
Enzyme could be new target for cancer immunotherapies
Interim Statement on Covid vaccines in context of circulation of Omicron SARS-CoV-2 Variant from WHO Technical Advisory Group 8 March
Are medicines affecting our response to infections like Covid?
Cancer: When viruses and bacteria cooperate
ATAGI recommendations on use of Spikevax Covid vaccine in children aged 6 to 11 years
Cannibal immune cells could offer new treatment path
International Day of Women and Girls in Science
Ludwig Cancer Research study identifies potential vulnerability in drug-resistant neuroblastoma
Advanced prostate cancer antibody drug shows success in pet dogs
ATAGI statement on use of Novavax Covid vaccine
Interim Statement on Covid vaccines in context of circulation of Omicron SARS-CoV-2 Variant from WHO Technical Advisory Group
Spleen function discovery could lead to better treatments for infectious diseases
Common osteoporosis medication boosts immune response in lun
Early data for multivariant Covid vaccine booster shows promise
Vaxzevria significantly boosted antibody levels against Omicron
Interim statement on booster doses for Covid vaccination 23 December
Researchers working on injection-free cell therapy for diabetes
Scientists find new details about how immune system builds long-term memory
Tumors differ depending on age of cancer patients
Brain immune cells sense low dose radiation
Targeting brain’s immune cells may block Alzheimer’s
Classification of Omicron: SARS-CoV-2 Variant of Concern